The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and enterprise funds partners, which includes Celgene, General Electric Ventures, and Eli Lilly, committed a minimal of $100 million to help launch 15 to 20 ventures in life sciences and biotechnology. On December 19, 2011, Mayor Michael R.